GNI-50 - SBI796768

Based on 4 reference(s) in Google Scholar 8 10 4

Axon 3952

CAS [1363154-45-3]

MF C19H22N4O4S
MW 402.47

  • Purity: 98%
  • Soluble in 0.1N HCl(aq) and DMSO
Recently added

GNI-50

Description

GNI-50 is an orally active NAMPT inhibitor which exhibited excellent biochemical and cellular (A2780) potency with IC50 values of 0.007 μM and 0.032 μM, respectively. GNI-50 also showed excellent in vivo antitumor efficacy when dosed orally in an A2780 ovarian tumor xenograft model.

KEYWORDS: GNI-50 | Supplier | NAMPT inhibitor | SBI796768 | GNI50 | GNI 50 | SBI 796768 | SBI796768 | CAS [1363154-45-3] | Nicotinamide D-ribonucleotide | NAMPT | Inhibitor | Enzymes | Nicotinamide phosphoribosyltransferase | Ovarian tumor

Order
Size Unit Price Stock
5 mg €110.00 In Stock
25 mg €380.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...